IQVIA’s cover photo
IQVIA

IQVIA

Hospitals and Health Care

Durham, North Carolina 2,722,459 followers

See jobs Follow

About us

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.

Website
https://www.iqvia.com/
Industry
Hospitals and Health Care
Company size
10,001+ employees
Headquarters
Durham, North Carolina
Type
Public Company
Specialties
Technology, Consulting, and Clinical Development

Locations

Employees at IQVIA

See all employees

Updates

  • View organization page for IQVIA
    IQVIA

    2,722,459 followers

    As development timelines come under increasing pressure, sponsors are rethinking what drives study success. Andy Lee, Head of Site Activation, Asia, shares insights on how site activation strategy can improve speed, predictability and execution outcomes..

    View organization page for IQVIA Asia Pacific
    IQVIA Asia Pacific

    78,805 followers

    Trial start-up sets the pace for everything that follows in clinical development. As studies become increasingly complex, efficient site activation is becoming a critical factor in delivering timelines. Andy Lee, Head of Site Activation, Asia, examines how different JAPAC markets approach site activation and why understanding country-specific strengths matters when planning clinical development programs. Read the blog to learn why treating JAPAC as a single geography may mean overlooking important opportunities: https://lnkd.in/eXqwDRuB

    • No alternative text description for this image
  • View organization page for IQVIA
    IQVIA

    2,722,459 followers

    Medical Affairs teams are moving beyond simply creating more content and toward connected content ecosystems that improve relevance, efficiency, and HCP engagement. Discover how AI-enabled content strategies can help maximize the value of existing knowledge and reduce duplication. Read the article.

  • View organization page for IQVIA
    IQVIA

    2,722,459 followers

    The question is no longer whether we can detect outbreak threats early. The question is whether our systems and partnerships are ready to act on them in time. As global leaders prepare for this year's UN General Assembly High-Level Meeting on Pandemic Prevention, Preparedness and Response, the discussion is increasingly focused on turning early warning into early action. A new article published by the World Economic Forum, co-authored by IQVIA's Daniel Mora-Brito, explores how trusted partnerships, interoperable data systems and stronger governance can help close that gap: https://lnkd.in/eyFNwwrw

    • No alternative text description for this image
  • View organization page for IQVIA
    IQVIA

    2,722,459 followers

    Just announced: Vivian S. Lee, MD, PhD, MBA will take the stage at IQVIA TechIQ 2026. A physician, healthcare executive and author, Vivian brings a unique perspective shaped by leadership roles across healthcare, technology and innovation. Join us as she shares her views on the future of healthcare, the impact of emerging technologies and the opportunities and challenges facing industry leaders. Join us in Boston, October 7-8. Places are limited. Register today: https://bit.ly/3RWk9KV

    • No alternative text description for this image
  • View organization page for IQVIA
    IQVIA

    2,722,459 followers

    Earlier diagnosis can make a meaningful difference in the lives of people living with type 1 diabetes. Learn how IQVIA Healthcare-grade AI® and our award-winning collaboration with Breakthrough T1D are helping improve identification of adult-onset T1D and support better clinical decision-making.

    View organization page for IQVIA Technologies
    IQVIA Technologies

    33,176 followers

    What happens when someone who experienced a delayed type 1 diabetes diagnosis helps build a tool to improve earlier detection? IQVIA's Joe McFadden shares his personal perspective and discusses the AI model developed with Breakthrough T1D that won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year. Powered by IQVIA Healthcare-grade AI®, the tool improves identification of adult-onset type 1 diabetes, reducing screening burden by 99.5% (from approximately 60,000 to 300 patients). Watch the full interview featuring experts from IQVIA and Breakthrough T1D: https://lnkd.in/et_nU_Zb

Affiliated pages

Similar pages

Browse jobs